Get Premium to unlock powerful stock data

Commodore Capital Lp Buys Dicerna Pharmaceuticals Inc, IVERIC bio Inc, Merus NV, Sells , Macrogenics Inc, ESSA Pharma Inc

Author's Avatar
insider
Nov 29, 2021
Article's Main Image
Investment company Commodore Capital Lp (Current Portfolio) buys Dicerna Pharmaceuticals Inc, IVERIC bio Inc, Merus NV, Tenaya Therapeutics Inc, Aclaris Therapeutics Inc, sells , Macrogenics Inc, ESSA Pharma Inc, Mersana Therapeutics Inc, Seres Therapeutics Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Commodore Capital Lp. As of 2021Q3, Commodore Capital Lp owns 29 stocks with a total value of $379 million. These are the details of the buys and sells.

For the details of COMMODORE CAPITAL LP's stock buys and sells, go to https://www.gurufocus.com/guru/commodore+capital+lp/current-portfolio/portfolio

These are the top 5 holdings of COMMODORE CAPITAL LP
  1. IVERIC bio Inc (ISEE) - 2,750,137 shares, 11.78% of the total portfolio. Shares added by 57.31%
  2. Aclaris Therapeutics Inc (ACRS) - 2,190,291 shares, 10.39% of the total portfolio. Shares added by 31.23%
  3. Cytokinetics Inc (CYTK) - 796,578 shares, 7.51% of the total portfolio. Shares added by 13.10%
  4. Dicerna Pharmaceuticals Inc (DRNA) - 1,292,251 shares, 6.87% of the total portfolio. New Position
  5. C4 Therapeutics Inc (CCCC) - 481,094 shares, 5.67% of the total portfolio.
New Purchase: Dicerna Pharmaceuticals Inc (DRNA)

Commodore Capital Lp initiated holding in Dicerna Pharmaceuticals Inc. The purchase prices were between $19.68 and $39.99, with an estimated average price of $27.67. The stock is now traded at around $38.080000. The impact to a portfolio due to this purchase was 6.87%. The holding were 1,292,251 shares as of 2021-09-30.

New Purchase: Merus NV (MRUS)

Commodore Capital Lp initiated holding in Merus NV. The purchase prices were between $16.48 and $27.23, with an estimated average price of $21.52. The stock is now traded at around $24.980000. The impact to a portfolio due to this purchase was 4.17%. The holding were 718,136 shares as of 2021-09-30.

New Purchase: Tenaya Therapeutics Inc (TNYA)

Commodore Capital Lp initiated holding in Tenaya Therapeutics Inc. The purchase prices were between $15.35 and $26.66, with an estimated average price of $21.56. The stock is now traded at around $18.690000. The impact to a portfolio due to this purchase was 2.8%. The holding were 513,930 shares as of 2021-09-30.

New Purchase: Iovance Biotherapeutics Inc (IOVA)

Commodore Capital Lp initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $18.240000. The impact to a portfolio due to this purchase was 2.36%. The holding were 362,869 shares as of 2021-09-30.

New Purchase: Revolution Medicines Inc (RVMD)

Commodore Capital Lp initiated holding in Revolution Medicines Inc. The purchase prices were between $23.95 and $33.41, with an estimated average price of $29.16. The stock is now traded at around $26.700000. The impact to a portfolio due to this purchase was 1.64%. The holding were 226,228 shares as of 2021-09-30.

Added: IVERIC bio Inc (ISEE)

Commodore Capital Lp added to a holding in IVERIC bio Inc by 57.31%. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $15.040000. The impact to a portfolio due to this purchase was 4.29%. The holding were 2,750,137 shares as of 2021-09-30.

Added: Aclaris Therapeutics Inc (ACRS)

Commodore Capital Lp added to a holding in Aclaris Therapeutics Inc by 31.23%. The purchase prices were between $13.38 and $18.8, with an estimated average price of $16.07. The stock is now traded at around $12.270000. The impact to a portfolio due to this purchase was 2.47%. The holding were 2,190,291 shares as of 2021-09-30.

Added: Viridian Therapeutics Inc (VRDN)

Commodore Capital Lp added to a holding in Viridian Therapeutics Inc by 258.18%. The purchase prices were between $10.69 and $18.2, with an estimated average price of $14.67. The stock is now traded at around $17.970000. The impact to a portfolio due to this purchase was 2.09%. The holding were 667,674 shares as of 2021-09-30.

Added: Kura Oncology Inc (KURA)

Commodore Capital Lp added to a holding in Kura Oncology Inc by 60.81%. The purchase prices were between $15.42 and $21.72, with an estimated average price of $18.88. The stock is now traded at around $13.940000. The impact to a portfolio due to this purchase was 1.87%. The holding were 999,433 shares as of 2021-09-30.

Added: Protagonist Therapeutics Inc (PTGX)

Commodore Capital Lp added to a holding in Protagonist Therapeutics Inc by 136.50%. The purchase prices were between $12.95 and $49.69, with an estimated average price of $42.78. The stock is now traded at around $32.570000. The impact to a portfolio due to this purchase was 1.34%. The holding were 498,079 shares as of 2021-09-30.

Added: VistaGen Therapeutics Inc (VTGN)

Commodore Capital Lp added to a holding in VistaGen Therapeutics Inc by 53.80%. The purchase prices were between $2.62 and $3.45, with an estimated average price of $2.91. The stock is now traded at around $1.860000. The impact to a portfolio due to this purchase was 1.29%. The holding were 5,123,509 shares as of 2021-09-30.

Sold Out: (CNST)

Commodore Capital Lp sold out a holding in . The sale prices were between $33.9 and $33.99, with an estimated average price of $33.95.

Sold Out: Macrogenics Inc (MGNX)

Commodore Capital Lp sold out a holding in Macrogenics Inc. The sale prices were between $19.74 and $28.7, with an estimated average price of $24.13.

Sold Out: ESSA Pharma Inc (EPIX)

Commodore Capital Lp sold out a holding in ESSA Pharma Inc. The sale prices were between $7.76 and $29.37, with an estimated average price of $15.99.

Sold Out: Mersana Therapeutics Inc (MRSN)

Commodore Capital Lp sold out a holding in Mersana Therapeutics Inc. The sale prices were between $8.56 and $14.47, with an estimated average price of $11.75.

Sold Out: Seres Therapeutics Inc (MCRB)

Commodore Capital Lp sold out a holding in Seres Therapeutics Inc. The sale prices were between $5.46 and $22.6, with an estimated average price of $9.91.

Reduced: Celldex Therapeutics Inc (CLDX)

Commodore Capital Lp reduced to a holding in Celldex Therapeutics Inc by 23.26%. The sale prices were between $28.95 and $55.99, with an estimated average price of $46.84. The stock is now traded at around $38.720000. The impact to a portfolio due to this sale was -0.88%. Commodore Capital Lp still held 248,207 shares as of 2021-09-30.



Here is the complete portfolio of COMMODORE CAPITAL LP. Also check out:

1. COMMODORE CAPITAL LP's Undervalued Stocks
2. COMMODORE CAPITAL LP's Top Growth Companies, and
3. COMMODORE CAPITAL LP's High Yield stocks
4. Stocks that COMMODORE CAPITAL LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus